» Articles » PMID: 27661081

Decreased Sperm Motility Retarded ICSI Fertilization Rate in Severe Oligozoospermia but Good-Quality Embryo Transfer Had Achieved the Prospective Clinical Outcomes

Overview
Journal PLoS One
Date 2016 Sep 24
PMID 27661081
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Spermatozoa motility is the critical parameter to affect the treatment outcomes during assisted reproductive technologies (ART), but its reproductive capability remains a little informed in condition of severe male factor infertility. This retrospective cohort study aimed to evaluate the effects of reduced sperm motility on the embryological and clinical outcomes in intra-cytoplasmic sperm injection (ICSI) treatment of severe oligozoospermia.

Patients And Methods: 966 cycles (812 couples) of severe oligozoospermia diagnosed by spermatozoa count ≤ 5 × 106/mL and motile spermatozoa ≤ 2 × 106/mL were divided into four groups in according to the number of motile spermatozoa in one ejaculate on the day of oocyte retrieval (Group B-E). The control (Group A) was 188 cycles of moderate oligozoospermia with spermatozoa count > 5 × 106/mL and motile spermatozoa > 2 × 106/mL. All female partners were younger than 35 years of age. Logistic regression analyzed embryological outcomes (the rates of fertilization, cleavage and good-quality embryo) and clinical outcomes (the rates of pregnancy, implantation, early miscarriage and live birth). Quality of embryo transfer (ET) was divided into three classes as continuous factor to test the effects of embryo quality on clinical outcomes.

Results: The reduction in the number of motile sperm in four groups of severe oligozoospermia gave rise to comparable inability of the fertilization (p < 0.001) and a decreased rate of good-quality embryo at Day 3 (p < 0.001) by compared to the control. The cleavage rate of the derived zygotes was similar to the control. ET classes significantly affected the clinical outcomes (p < 0.001). Class I ET gave rise to similar rates of clinical outcomes between five groups, but Class II and Class III ET retarded the rates of pregnancy, implantation and live birth and this particularly occurred in Group C, D and E. The rate of early miscarriage was not comparably different between groups. Overall rates in all groups were 41.26% clinical pregnancy, 25.74% implantation and 36.32% live birth, which gave live birth to 252 girls and 252 boys.

Conclusions: The reduction of motile spermatozoa in severe oligozoospermia decreased the rates of fertilization and good-quality embryo. Obtaining and transfer of good-quality embryos was the good prognostic to achieve prospective clinical outcomes regardless of the severity of oligozoospermia.

Citing Articles

Cumulus matrix selection leads to isolation of spermatozoa with better motility, morphology, and lower DNA fragmentation.

Handzhiyska M, Ganeva R, Parvanov D, Ruseva M, Eftimov P, Georgieva V Reprod Fertil. 2024; .

PMID: 38670151 PMC: 11227069. DOI: 10.1530/RAF-23-0052.


Making immotile sperm motile using high-frequency ultrasound.

Vafaie A, Raveshi M, Devendran C, Nosrati R, Neild A Sci Adv. 2024; 10(7):eadk2864.

PMID: 38354240 PMC: 10866541. DOI: 10.1126/sciadv.adk2864.


The Impact of Supplementation on Human Asthenozoospermic Sperm Parameter Quality.

Zarhouti A, Mbaye M, Addoum B, Louanjli N, El Khalfi B, Soukri A ScientificWorldJournal. 2023; 2023:8093795.

PMID: 37440992 PMC: 10335756. DOI: 10.1155/2023/8093795.


A comprehensive investigation of human endogenous retroviral syncytin proteins and their receptors in men with normozoospermia and impaired semen quality.

Tas G, Soygur B, Kutlu O, Sati L J Assist Reprod Genet. 2022; 40(1):97-111.

PMID: 36469256 PMC: 9734899. DOI: 10.1007/s10815-022-02673-z.


Nomogram models to predict low fertilisation rate and total fertilisation failure in patients undergoing conventional IVF cycles.

Wang Q, Wan Q, Bu X, Feng Q, Li T, Lv X BMJ Open. 2022; 12(11):e067838.

PMID: 36428025 PMC: 9703318. DOI: 10.1136/bmjopen-2022-067838.


References
1.
Maduro M, Lamb D . Understanding new genetics of male infertility. J Urol. 2002; 168(5):2197-205. DOI: 10.1016/S0022-5347(05)64355-8. View

2.
Lilford R, Jones A, Bishop D, Thornton J, Mueller R . Case-control study of whether subfertility in men is familial. BMJ. 1994; 309(6954):570-3. PMC: 2541440. DOI: 10.1136/bmj.309.6954.570. View

3.
Cooper T, Noonan E, von Eckardstein S, Auger J, Baker H, Behre H . World Health Organization reference values for human semen characteristics. Hum Reprod Update. 2009; 16(3):231-45. DOI: 10.1093/humupd/dmp048. View

4.
Lu J, Huang Y, Lu N . [WHO Laboratory Manual for the Examination and Processing of Human Semen: its applicability to andrology laboratories in China]. Zhonghua Nan Ke Xue. 2011; 16(10):867-71. View

5.
Rogenhofer N, Dansranjavin T, Schorsch M, Spiess A, Wang H, von Schonfeldt V . The sperm protamine mRNA ratio as a clinical parameter to estimate the fertilizing potential of men taking part in an ART programme. Hum Reprod. 2013; 28(4):969-78. DOI: 10.1093/humrep/des471. View